BWS Financial reiterated their buy rating on shares of TriMas (NASDAQ:TRS - Free Report) in a research report report published on Thursday,Benzinga reports. The firm currently has a $40.00 price target on the industrial products company's stock.
Separately, StockNews.com raised TriMas from a "sell" rating to a "hold" rating in a research report on Wednesday, November 13th.
View Our Latest Analysis on TriMas
TriMas Trading Up 3.3 %
Shares of TriMas stock traded up $0.82 on Thursday, hitting $25.42. 258,010 shares of the company's stock traded hands, compared to its average volume of 219,115. TriMas has a one year low of $22.24 and a one year high of $28.51. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The company has a fifty day moving average of $25.07 and a two-hundred day moving average of $25.44. The company has a market capitalization of $1.03 billion, a price-to-earnings ratio of 39.72 and a beta of 0.67.
TriMas (NASDAQ:TRS - Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share for the quarter, missing analysts' consensus estimates of $0.57 by ($0.14). TriMas had a return on equity of 9.21% and a net margin of 2.93%. The firm had revenue of $229.36 million for the quarter, compared to analyst estimates of $239.33 million. During the same period last year, the company posted $0.57 earnings per share. The firm's quarterly revenue was down 2.5% compared to the same quarter last year. As a group, sell-side analysts expect that TriMas will post 1.69 earnings per share for the current year.
Institutional Investors Weigh In On TriMas
A number of large investors have recently added to or reduced their stakes in TRS. Aristides Capital LLC purchased a new position in shares of TriMas in the second quarter worth about $245,000. Intech Investment Management LLC purchased a new position in shares of TriMas in the third quarter worth about $269,000. Paloma Partners Management Co bought a new stake in shares of TriMas in the third quarter worth about $293,000. XTX Topco Ltd bought a new stake in shares of TriMas in the third quarter worth about $371,000. Finally, Algert Global LLC grew its stake in shares of TriMas by 4.2% in the second quarter. Algert Global LLC now owns 15,779 shares of the industrial products company's stock worth $403,000 after purchasing an additional 639 shares during the last quarter. Hedge funds and other institutional investors own 99.42% of the company's stock.
TriMas Company Profile
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Articles
Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.